• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A Joint Study of Features and Treatment of Urogenital Disorders in Japan and People's Republic of China

Research Project

Project/Area Number 02044049
Research Category

Grant-in-Aid for Overseas Scientific Survey.

Allocation TypeSingle-year Grants
Research InstitutionDepartment of Urology, Tokyo Medical and Dental University

Principal Investigator

OSHIMA Hiroyuki  Professor of Urology, Tokyo Medical and Dental University, 医学部・泌尿器科, 教授 (60013934)

Co-Investigator(Kenkyū-buntansha) 那 彦群  北京医科大学, 副教授
郭 慶禄  北京医科大学, 教授
〓 方六  北京医科大学, 教授
KIHARA Kzunori  Assistant Professor of Urology, 医学部泌尿器科, 助手 (40161541)
GOTOH Syuichi  Instructor of Urology, 医学部泌尿器科, 講師 (30143580)
FUKUI Iwao  Associate Professor of Urology, 医学部泌尿器科, 助教授 (90014232)
Project Period (FY) 1990
Project Status Completed (Fiscal Year 1990)
KeywordsJoint study / Japan / China / Chemotherapy / Urogenital cancer / Urogenital anomaly
Research Abstract

A joint study of features and treatment of urogenital disorders was started in May, 1990. Mean inpatients number is 400 per year at urological service, Beijing Medical School. Purposes of this study are to evaluate the neoadjuvant chemotherapy of invasive bladder cancer, castration plus chemotherapy for the advanced prostatic cancer and the incidence of congenital anomaly.
Results are as follows :
1) For neoadjuvant chemotherapy of invasive bladder cancer, 8 patients were treated with CDDP arterial instillation method. Partial tumor regression was revealed in all patients with surgically resected materials. It seems that this therapy is also available in China because of tumor regression effect with low toxicity.
2) 7 cases of prostatic cancer with bone metastasis were treated with castration and IFAP (Ifosphamide, 5FU, Adriacin and CDDP) chemotherapy. This combination therapy is effective with not only pain relief but also accelerated reduction of serum tumor markers levels. Long follow up is needed.
3) The incidence of congenital anomaly in inpatients is 8% in both institutes. And it is also the same situation that undescended testis and urethral hypospadia are the most common congenital anomalies.

Report

(1 results)
  • 1990 Final Research Report Summary
  • Research Products

    (3 results)

All Other

All Publications (3 results)

  • [Publications] 関根 英明: "膀胱癌に対するCisplatinとSodiam Thiosulfateによる2経路化学療法" 泌尿器科紀要. 32. 43-48 (1986)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1990 Final Research Report Summary
  • [Publications] 寿美 周平: "表在性乳頭状膀胱腫瘍の予後因子としての腫瘍数に関する統計学的解析" 日本泌尿器科会誌. 81. 1384-1388 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1990 Final Research Report Summary
  • [Publications] 竹内 信一: "Stage O^2前立腺癌に対するEfosfanide,5FO,Gsplatin併用化学療法" 泌尿器科紀要. 35. 1513-1517 (1989)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1990 Final Research Report Summary

URL: 

Published: 1993-08-12   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi